Le Lézard
Classified in: Health
Subjects: RCL, PSF, CFG

Public Health Notice: Outbreak of Salmonella infections linked to Malichita brand cantaloupes


OTTAWA, ON, Nov. 22, 2023 /CNW/ - Update

Why you should take note

The Public Health Agency of Canada (PHAC) is collaborating with federal and provincial public health partners, the United States Centers for Disease Control and Prevention (U.S. CDC), and the U.S. Food and Drug Administration (FDA) to investigate an outbreak of Salmonella infections in five provinces: British Columbia, Ontario, Quebec, Prince Edward Island and Newfoundland and Labrador.

Based on the investigation findings to date, consumption of Malichita brand cantaloupe has been identified as the likely source of the outbreak. Some of the individuals who became sick reported having eaten cantaloupe before their illnesses occurred.

The CFIA issued food recall warnings on November 1 and November 14 for Malichita brand cantaloupes sold between October 11 and November 14, 2023. The recalled product was distributed in Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Nova Scotia, Ontario, Prince Edward Island, Quebec, and possibly other provinces and territories. Additional secondary recalls have been issued for products that were made using the recalled Malichita brand cantaloupe and for produce items that were processed alongside Malichita brand cantaloupes. This includes other fruit like honeydew, pineapple, watermelon and various fruit trays. For more information on the recalled products, please consult CFIA's recall notice.

The CFIA is continuing its food safety investigation, which may lead to the recall of other products. If other products are recalled, the CFIA will notify the public through additional food recall warnings.

To prevent illness, do not eat, serve, use, sell, or distribute Malichita brand cantaloupe, any products made with Malichita brand cantaloupe, or any recalled produce. If you are unable to verify the brand of cantaloupe, or if your produce is part of the CFIA recalls, it is recommended to throw it out. This advice applies to individuals, as well as retailers, distributors, manufacturers, food service establishments such as hotels, restaurants, cafeterias, and facilities such as hospitals, long-term care homes and daycares, across Canada.

This public health notice will be updated as the investigation evolves.

Symptoms

Symptoms typically start 6 to 72 hours after exposure to Salmonella bacteria, and usually last for 4-7 days.

Symptoms may include:

People who are infected with Salmonella bacteria can spread Salmonella to other people several days to several weeks after they have become infected, even if they don't have symptoms. Salmonella can spread by person to person contact and contaminated surfaces. Most people who become ill from a Salmonella infection will recover fully after a few days without treatment, but it can also cause severe illness and hospitalization.

Anyone can become sick with a Salmonella infection. If you think you're experiencing symptoms, contact your health care provider.

Those at higher risk for serious illness include:

What you should do to protect your health

The following advice applies to individuals, as well as retailers, distributors, manufacturers, food service establishments such as hotels, restaurants, cafeterias, and facilities such as hospitals, long-term care homes and daycares, across Canada:

Additional information

SOURCE Public Health Agency of Canada


These press releases may also interest you

at 04:19
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that an abstract for the combination of fostroxacitabine bralpamide (fostrox) + Lenvima® in...

at 04:15
Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced the expansion of its LV Edge System with the launch of a fully stable cell line development service. There are now two ways for customers to...

at 04:07
Huma Therapeutics ("Huma"), a leader in global digital health innovation, together with Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the launch of their innovative bladder cancer treatment companion app in...

at 04:00
Calibre Scientific is pleased to announce the acquisition of Camlab Limited ("Camlab" or the "Company"), a UK-based supplier of scientific equipment, chemicals, consumables, labware, and other laboratory supplies and services to customers in the...

at 04:00
Hurom, a pioneer in the development of the slow juicer and a leader in the global market, is stepping up efforts to safeguard patent rights worldwide to protect its proprietary technology and contribute to a healthy industry ecosystem. Despite...

at 03:46
Allied Market Research published a report titled, "Biosimilar Testing and Development Services Market Share, Size, Competitive Landscape and Trend Analysis Report by Type, by End User: Global Opportunity Analysis and...



News published on and distributed by: